PAR
Click for more information
2.17% 23.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-4286

  1. Beaza79
    5,157 Posts.
    lightbulb Created with Sketch. 663
    clock Created with Sketch.
    21/07/24
    15:07
    Post #: 74846601
    I assume this is after phase 2. If they are bought out during phase 3 trials they wouldn’t be classified as phase 2
    PAR Price at posting: 29.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
UNT UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off
right-arrow Created with Sketch.
NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢ 		Change
0.005(2.17%) 		Mkt cap ! $80.45M
Open High Low Value Volume
23.5¢ 24.0¢ 22.5¢ $170.1K 733.8K

Buyers (Bids)

No. Vol. Price($)
2 15000 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 13397 4
View Market Depth
Last trade - 12.53pm 23/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.